Publication | Closed Access

Ipragliflozin (ASP1941), a selective sodium-dependent glucose cotransporter 2 inhibitor, safely stimulates urinary glucose excretion without inducing hypoglycemia in healthy Japanese subjects

Metabolic SyndromeDiabetes ManagementUrinary Glucose ExcretionMedicinePhysiologyDiabetesChronic Kidney DiseasePharmacotherapyHealthy Japanese SubjectsDiabetes MellitusPharmacologyHealth Sciences